ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Anormed Ord (MM)

Anormed Ord (MM) (ANOR)

0.00
0.00
(0.00%)
마감 05 11월 6:00AM
0.00
0.00
(0.00%)
시간외 거래: -

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
-
매수가
-
매도가
-
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
전일 종가
-
개장가
-
최근 거래 시간
마지막 거래 시간
평균 볼륨(3m)
-
재정 규모
-
VWAP
-

ANOR 최신 뉴스

Genzyme Completes Tender Offer for Outstanding Shares of AnorMED

Acquisition to Strengthen Transplant and Oncology Businesses CAMBRIDGE, Mass. and VANCOUVER, B.C., Nov. 7 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) and AnorMED Inc. (Nasdaq:...

Genzyme and AnorMED Announce Completion of Hart-Scott-Rodino Review

CAMBRIDGE, Mass. and VANCOUVER, B.C., Nov. 7 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) and AnorMED Inc. (Nasdaq: ANOR; TSX: AOM) announced today the expiration of the waiting...

AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events

AnorMED Board Recommends Shareholders Accept Genzyme Offer LANGLEY, BC, Nov. 3 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or the "Company") (NASDAQ:ANOR; TSX:AOM) today released its...

Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical Officer

SEATTLE, Oct. 26 /PRNewswire/ -- Koronis Pharmaceuticals, Inc. today announced the appointment of Stephen Becker, M.D., as chief medical officer. Dr. Becker joins Koronis from AnorMED...

AnorMED completes enrollment in Phase III trial for MOZOBIL on schedule

VANCOUVER, Oct. 23 /PRNewswire-FirstCall/ -- AnorMED Inc. (NASDAQ:ANOR; TSX:AOM) today announced that it has completed enrollment in the second pivotal Phase III clinical trial evaluating its...

AnorMED and Genzyme reach agreement on acquisition

Genzyme to Gain Late-Stage Transplantation Product Candidate VANCOUVER, BC, and CAMBRIDGE, MA, Oct. 17 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) and AnorMED Inc. (Nasdaq: ANOR;...

AnorMED has determined Genzyme's offer is a 'superior proposal'

Millennium has the right to match Genzyme's 'superior proposal' VANCOUVER, Oct. 11 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or "the Company") (NASDAQ:ANOR; TSX:AOM) announced that it...

AnorMED has determined Genzyme's offer is a 'superior proposal'

Millennium has the right to match Genzyme's 'superior proposal' VANCOUVER, Oct. 11 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or "the Company") (NASDAQ:ANOR; TSX:AOM) announced that it...

AnorMED announces receipt of proposal from Genzyme Corporation

VANCOUVER, Oct. 10 /PRNewswire-FirstCall/ -- AnorMED Inc. (NASDAQ:ANOR; TSX:AOM) announced today that it has received a proposal from Genzyme Corporation (NASDAQ:GENZ), acting through its wholly...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
SPPLSIMPPLE Ltd
US$ 1.18
(268.75%)
401.7M
NUWENewellis Inc
US$ 2.80
(105.88%)
100.16M
ADNAdvent Technologies Holdings Inc
US$ 3.34
(75.79%)
66.84M
STAFStaffing 360 Solutions Inc
US$ 2.8301
(66.48%)
53.09M
OMICSingular Genomics Systems Inc
US$ 22.28
(65.53%)
323.71k
TOIIWOncology Institute Inc
US$ 0.0101
(-47.67%)
58.23k
SSPEW Scripps Company
US$ 2.2701
(-35.51%)
4.25M
GCTKGlucoTrack Inc
US$ 1.15
(-33.91%)
82.44k
ILLRTriller Group Inc
US$ 2.86
(-33.18%)
2.32M
FGFFundamental Global Inc
US$ 15.2501
(-31.46%)
209.53k
SPPLSIMPPLE Ltd
US$ 1.18
(268.75%)
401.7M
ELABElevai Labs Inc
US$ 0.0202
(-30.10%)
290.47M
NVDANVIDIA Corporation
US$ 136.05
(0.48%)
187.51M
SQQQProShares UltraPro Short QQQ
US$ 7.52
(1.08%)
167.29M
DJTTrump Media and Technology Group Corporation
US$ 34.34
(12.37%)
120.89M
kayak_wench kayak_wench 1 분 전
The large growth in revenue from 2022 to 2023 was directly related to Elite going to their own label in 2023. Most importantly it was their doing the sales of Adderall rather than Lannette who wasn't trying very hard at all to penetrate market share at all. That was the reason for the big increas
ELTP
Eli's Gone Eli's Gone 1 분 전
Getting into the wall wasn't the issue----keeping the car floored and riding the wall thru turns 3 and 4 was....
RDY2ROCK RDY2ROCK 2 분 전
OTCM knows exactly what's going on....OTCN is their Broker-Dealer manipulating their OTC stocks by design! OTCM acts like their the good guy/gal, but is the Wolf in Sheep clothing using their OTCN Broker-Dealer to manipulate OTC stocks!

The big guns, new change in control and Balkin m
AFFU OTCM
konshe konshe 2 분 전
see rebound to 0.002 begin Tomorrow This is oversold stock by bashews The compony' s value now is undervalued
ASII
lambchops lambchops 3 분 전
The pic on the right looks like my daddy-ram!, Sam.
Nice to know you're an efficiency doggy, too.

LC

NFTM
NFTM
zakattack zakattack 4 분 전
you think gncp is worth 50 idk about that i'd pay ron 5 dollars for the whole company and throw in a burger and fries with a frosty
GNCP
New money98 New money98 4 분 전
Lolllll you're funny, Bioaq is going down in the record books. That's why you're here besides the fact that you can't leave. But hey, hurry and get to 10k we will have a 10k post party. Non-stop day in and day out for 6years is commendable. Definitely better than me and I have shares, you go girl!
SparklingNavigator24 SparklingNavigator24 4 분 전
The combo trial has a very good chance of extending the patent on Keytruda. How much will Merck pay?
NWBO
aljafy aljafy 5 분 전
Yeah, Ben hasn't been berry berry good lately. Hoping the Cohen trifecta fares better.
AZRH
janice shell janice shell 5 분 전
He is indeed. Do you think he'll thank more than one of us for playing?
blackhawks blackhawks 5 분 전
And I wouldn't count on your analysis of what you post. From the top link in your post.

https://abcnews.go.com/Politics/gender-gap-decide-2024-election/story?id=115272924

The final ABC News/Ipsos poll before Election Day, released on Sunday, found the gender gap among a
Money hunt Money hunt 8 분 전
Shorties having fun shorting with ctb at 774.41 huge run coming
ELAB
solidgold solidgold 9 분 전
Thank you. Keep us posted.
NBRI
janice shell janice shell 9 분 전
I beg your pardon? That is not a reason to vote for toxic bullies like Trump.
236T568 236T568 10 분 전
Now is is funny, VERY VERY funny

https://x.com/seacorc/status/1853627809568039281
MightyX MightyX 11 분 전
How much time y’all require to jack-up price prior to significant new money buying shares outside yalls group?
TPTW
againstallodds againstallodds 11 분 전
Meaningless, inner circle trading to walk up sp

Typical of mining “plays” as you call them

Waiting for the only thing that matters: gold delivery

The other stuff only shows lack of focus from JarHead
NBRI
1hunglo 1hunglo 12 분 전
IDK if this next statement will ever be relevant to the progress of RDGL but I recalled verbage from the 2024 August Report Executive Summary: “ Precision Radionuclide Therapy was approved for publication on the website of the Ministry of Commerce and Industry in Saudi Arabia. “
Could this be
RDGL